Skip to main content

Advertisement

Table 1 Growth data of the subjects compared to the controls

From: Weight loss on stimulant medication: how does it affect body composition and bone metabolism? – A prospective longitudinal study

  All subjects All subjects All subjects DXA Controls
Baseline n=34 6 months n=30 36 months n=24 n=241
Mean ± sd Range Mean ± sd Range Mean ± sd Range Mean ± sd Range
Age (years) 7.27 ± 1.30*** 4.71-9.12 7.99 ± 1.21* 5.33-9.64 10.49 ± 1.22*** 7.87-12.21 8.54 ± 1.93 4.02-11.99
Height (cm) 125.5 ± 9.1* 110.3-142.2 128.6 ± 9.2 112.6-145.6 140.6 ± 9.0*** 125.5-156.0 130.5 ± 12.7 94.5-161.6
Weight (kg) 27.0 ± 6.1 19.1-42.1 26.8 ± 5.9 19.3-42.2 34.4 ± 8.4** 25.0-56.0 29.0 ± 8.2 13.1-60.4
BMI (kg/m2) 17.0 ± 2.3 13.7-23.7 16.1 ± 2.3 12.9-23.0 17.3 ± 3.1 13.9-26.5 16.7 ± 2.2 13.3-25.6
Height Z-score 0.49 ± 0.99** −1.08-3.02 0.22 ± 0.95 −1.19-2.76 −0.07 ± 0.81 −1.18-1.67 −0.06 ± 0.97 −2.24-2.07
Weight Z-score 0.62 ± 0.97*** −1.60-2.95 0.04 ± 1.04 −1.86-2.63 −0.12 ± 0.87 −1.48-1.58 −0.05 ± 0.92 −2.25-2.23
BMI Z-score 0.52 ± 1.02** −1.88-2.31 −0.17 ± 1.21 −2.92-2.04 −0.16 ± 1.11 −2.45-1.97 0.03 ± 0.88 −2.11-2.09
  1. *p<0.05; **p<0.01; ***p<0.001 compared to DXA controls (independent samples t-test).
  2. DXA: Dual-energy X-ray absorptiometry.